Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Characteristics of studies included in the review

From: Epidemiology of multidrug-resistant tuberculosis (MDR-TB) in Ethiopia: a systematic review and meta-analysis of the prevalence, determinants and treatment outcome

Studies included in the review Study area Study population Study design Study period No of patients
[16] Demissie et al. 1997 Addis Ababa New PTB patients Cross-sectional study 1994 167
[17] Gebeyehu, 2001 Arsi Zone PTB patients Cross-sectional study 1997–98 195
[18] Bruchfeld, 2002 Addis Ababa PTB patients Cross-sectional study 2000 121
(19)Asmamaw et al., 2008 Addis Ababa New PTB patients Cross-sectional study 2004–5 173
[20] Meskel et al. 2008 Addis Ababa Previously treated PTB Cross-sectional study 2001–2 84
[21] Agonafir, 2010 Addis Ababa PTB patients Cross-sectional study 2005–6 107
[22] Abate et al., 2012 Addis Ababa Previously treated PTB Retrospective 2004–8 376
[23] Abebe et al. 2012 South western Ethiopia New PTB patients Cross-sectional study 2010–11 136
[24] Tessema et al. 2012 North Ethiopia PTB patients Cross-sectional study 2009 260
[25] Yimer et al. 2012 ARS major towns New PTB patients Cross-sectional study 2008 93
[26] Hussein et al. 2013 Bahirdar, Fitche & Ambo PTB patients Cross-sectional study 2011 102
[27] Biadglegne et al.2014 Bahirdar, Gondar & Dessie TB lymphadenitis Cross-sectional study 2012 226
[28] Esmael et al. 2014 Eastern ARS PTB patients Cross-sectional study 2010–11 230
[29] Daniel et al. 2014 Debre Birhan PTB patients Cross-sectional study 2013–14 40
[30] Seyoum et al. 2014 Eastern Ethiopia New PTB patients Cross-sectional study 2011–13 357
[31] Tekle et al. 2014 Benishangul & Awi PTB patients Cross-sectional study 2013–14 87
[32] Abdella et al., 2015 South western Ethiopia Previously treated PTB cross sectional 2012–13 79
[33] Adane et al. 2015 East Gojjam PTB patients Cross-sectional study 2011–12 89
[34] Maru et al. 2015 Dessie PTB patients Cross-sectional study 2012–13 118
(35)Mekonnen et al. 2015 North Gondar PTB patients Cross-sectional study 2014 124
[36] Ali et al. 2016 South Ethiopia PTB patients cross sectional 2013 109
[37] Hamussie et al. 2016 Arsi Zone PTB patients Cross-sectional study 2013–14 106
[38] Brhane et al., 2017 Jigjiga PTB patients cross sectional NR 98
[39] Mulisa et al. 2015 Oromia Region MDR & Non MDR TB Case control study 2013–14 439
[40] Dessalegn et al. 2016 Addis Ababa MDR & Non MDR TB Case control study NR 206
[41] Hirpa et al. 2013 Addis Ababa MDR & Non MDR TB Case control study 2011–12 268
[42] Deressa et al. 2014 Addis Ababa MDR & Non MDR TB Case control study 2013 384
[43] Assefa et al. 2017 Addis Ababa MDR & Non MDR TB Case control study 2013 710
[44] Tadesse et al. 2015 Addis Ababa MDR & Non MDR TB cross sectional 2008–11 439
[45] Molalign et al. 2015 Addis Ababa & Gondar MDR TB Cohort 2011–14 342
[46] Alene et al. 2016 North west Ethiopia MDR TB retrospective cohort 2010–15 242
[47] Getachew et al. 2013 Addis Ababa MDR TB retrospective cohort 2011–12 188
[48] Meressa et al. 2015 Addis Ababa MDR TB Cohort 2009–14 612
[49] Girum et al. 2017 South Ethiopia MDR TB retrospective cohort 2011–16 154
  1. ARS- Amhara Regional state MDR- TB = Multidrug resistant tuberculosis